Global decentralized studies will become a standard clinical trial design approach
The Pharma Data
MARCH 20, 2021
“Studies will embrace decentralized trial approaches as design options earlier in the clinical trial planning process,” Reites said. Sponsors and CROs will continue to be eager to bounce back and accelerate the drug development process after significant delays caused by the pandemic,” Reites said. .
Let's personalize your content